Viridian Therapeutics
VRDN
VRDN
84 hedge funds and large institutions have $328M invested in Viridian Therapeutics in 2022 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 21 increasing their positions, 18 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
29% less capital invested
Capital invested by funds: $459M → $328M (-$131M)
Holders
84
Holding in Top 10
6
Calls
$5.66M
Puts
–
Top Buyers
| 1 | +$14.7M | |
| 2 | +$8.69M | |
| 3 | +$7.95M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.67M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.44M |
Top Sellers
| 1 | -$19.2M | |
| 2 | -$8.78M | |
| 3 | -$5.22M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$4.05M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$1.81M |